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favirenz and positive urine test for cannabis - debunkng the
yth
.C. Koh1,∗, Z.W. Daniel Eh1, W.-Y. Lee1, T.Murgiah2, N.J. Ismail1,
.S. Tee1, A. Othman2
International Medical University, Seremban, Negeri Sembilan,
alaysia
Hospital Tuanku Ja’afar, Seremban, Negeri Sembilan, Malaysia
Background: Urine tests for cannabis were positive in some
f patients who were detained by law-enforcers. These patients,
n their defense, claimed that the test results were false-positives
aused by Efavirenz which they were taking for the treatment of
IV infection. While in detention, some patients were deprived
f their Highly Active Antiretroviral Therapy (HAART). This issue
as become controversial for the patients, the law-enforcement
gencies and the doctors treating these patients.
This study was done to evaluate if urine collected from patients
aking Efavirenz would produce positive urine test results for
annabis using the same urinalysismethod used byMalaysian law-
nforcement agencies.
Methods: Urine samples were collected from HIV-infected
atients taking Efavirenz as part of HAART and tested for cannabi-
oids using the AxSYM Cannabinoids Assay® (Abbott, USA) which
as a sensitivity of 13 ng/mL. Epidemiological data were collected
rom patient case notes and from face-to-face interviews. Descrip-
ive analysis was done using SPSS® v.17 for Windows.
Results: 44 patients on Efavirenz were recruited. The mean age
as 44.8 years (23-73 years), 12 (27.3%) females. Mean-years on
favirenz, 3.8 years (1-14 years). Mean CD4 cell count on HAART
nitiation, 123.7 cells/uL (4-377). All were compliant in taking
favirenz in the preceding 7days before recruitment and38 (86.4%)
ook Efavirenz within 30minutes of scheduled time while the rest
ook Efavirenz within 60minutes of scheduled time. 4 patients had
istory of detention by law-enforcers; 2 were taking Efavirenz at
he time, of which 1 tested positive for urine cannabis and he was
eprived of HAART during detention. Urine test for cannabis was
egative for all 44 patients.
Conclusion:Urine tests for cannabis (using theAxSYMCannabi-
oids Assay) were negative for all patients taking Efavirenz as part
f HAART in this study. These patientswere adherent toHAART.We
onclude that Efavirenz is unlikely to be the cause of positive urine
est for cannabis using the AxySYM Cannabinoids Assay which is
sed by law enforcement agencies in Malaysia.
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HIV-1 subtypes in Jayapura City, Papua Province Indonesia
A. Oktavian1, T.N. Kridaningsih1,∗, H.A. Wibowo2, M. Widiyanti1,
I. Wieke1, E. Fitriana1
1 National Institute Of Research and Development for Biomedicine
Papua, Jayapura, Indonesia
2 National Institute of Health Research and Development, Jakarta,
Indonesia
Background: Papua Province has the highest HIV prevalence
in Indonesia. In September 2011, there were 10.522 HIV/AIDS
cases cumulatively with 18% (1.914) cases from Jayapura City, with
95,08% were transmitted through heterosexual intercourse. There
is no data about HIV-1 subtypes in Jayapura City
A cross sectional serological survey was intended to identify the
subtype of HIV-1 in Jayapura City Papua Province, Indonesia
Methods: The study was carried out in two Voluntary Coun-
seling Testing Clinics in Jayapura Hospital and Abepura Hospital
among 60 subjects with HIV/AIDS on May to November 2011. We
used questioner for demographic data, history of illness variables
and serological test with PCR and DNA sequencing to indentify the
subtype of HIV-1, in two laboratory: Biomolocular Laboratory of
National Institute for Biomedicine Papua for PCR procedure and
Biomolecular laboratory of Centre for Biomedicine andBasicHealth
Technology Jakarta.
Results: We found 39 (65%) subjects with HIV subtype B, 20
(33%) subtype AE and 1 (3%), un subtype. 97,4% subtype B and 95,2%
non subtype B were heterosexual
Conclusion: There is no relation between HIV subtype with risk
factor of the infection in this study.
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Eight years of prevention of parent to child transmission ofHIV-
AIDS programme (PPTCT) in a tertiary care hospital in India
M. Kulkarni ∗, G.S. Vijay Kumar, A. Bhandiwad
JSS Medical College and Hospital, Mysore, India
Background: The PPTCT programmewas started in the country
in the year 2002 after a feasibility study in the 5 high prevalence
states and aimed to prevent perinatal transmission of HIV. It entails
counseling and testing of pregnant women in the integrated cen-
ters for counseling and testing (ICTC)s and single dose nevirapine
(SDNVP) for mother and baby.This study was carried out according to National AIDS Control
Organisation (NACO) protocols, with enrollment, counseling, test-
